Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - Other
Ratios

Viridian Therapeutics, Inc.\DE (VRDN) Long-Term Debt Issuances (2022 - 2023)

Viridian Therapeutics, Inc.\DE (VRDN) has 3 years of Long-Term Debt Issuances data on record, last reported at -$15.0 million in Q4 2023.

  • For Q4 2023, Long-Term Debt Issuances fell 3463.23% year-over-year to -$15.0 million; the TTM value through Dec 2024 reached -$14.6 million, up 2.97%, while the annual FY2025 figure was $55.0 million, N/A changed from the prior year.
  • Long-Term Debt Issuances reached -$15.0 million in Q4 2023 per VRDN's latest filing, down from $446000.0 in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $446000.0 in Q4 2022 and bottomed at -$15.0 million in Q4 2023.